Proprietary scoliosis nutrient therapies formulated to target the body systems affected by the 28 genetic variants that cause the development and progression of idiopathic scoliosis in children and adults.
In 2012, unique patterns of hormone imbalances were first identified in patients with idiopathic scoliosis. Years later, it was confirmed that these hormone imbalances may decrease the chance of success for physical exercise treatments if they are corrected with targeted scoliosis nutrient therapies.
Patterns of neurotransmitter imbalances have been identified in patients with idiopathic scoliosis. These neurotransmitter imbalances can affect the chance of success for scoliosis treatment programs unless the imbalances are corrected. Our scoliosis nutrient therapies help to correct these concerns.
Bone density loss can lead to the development of scoliosis in adulthood, as well as allow existing scoliosis to rapidly worsen, such as during perimenopause. In childhood, low bone density can contribute to asymmetrical spinal growth, leading to curve acceleration during rapid growth spurts.
Click the images below to get more information about the ScoliSMART Doctors.